查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1523148

药物发现技术市场报告：2030 年趋势、预测与竞争分析

Drug Discovery Technology Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

药物发现技术的趋势和预测

到 2030 年，全球药物发现技术市场预计将达到 1,235 亿美元，2024 年至 2030 年复合年增长率为 9.1%。该市场的主要驱动力是慢性病的流行、药品消费的增加、研发投资的增加以及技术的快速发展。全球药物发现科技市场的未来充满希望，製药、生物製药、生技和研究机构市场充满机会。

药物发现技术的细分市场

该研究包括按技术、应用、最终用途行业、技术和地区对全球药物发现技术的预测。

药物发现技术市场洞察

Lucintel 预测，高通量筛检将在预测期内呈现最高成长。这是因为它作为一种药物发现方法在製药业被广泛采用，可以快速测试许多物质的生物或生化活性。

由于大量国际公司大力投资生物製药研发，生物製药公司可能仍是市场上最大的部分。

由于健康意识的提高、公共和私人医疗保健支出的增加以及生物技术和製药行业个性化医疗的兴起，对药物发现技术的需求不断增加，预计北美在预测期内将经历最高的增长。

常问问题

Q1.市场规模为：

A1. 到 2030 年，全球药物发现技术市场预计将达到 1,235 亿美元。

Q2.市场成长预测是多少：

A2. 2024年至2030年，全球药物发现技术市场预计将以9.1%的复合年增长率成长。

Q3.影响市场成长的主要驱动因素是：

A3.该市场的主要驱动因素是慢性病的增加、药品消费的增加、研发投资的增加以及技术的快速发展。

Q4.市场的主要细分市场是：

A4. 全球药物发现技术市场未来性广阔，製药、生物製药、生技和研究机构市场充满机会。

Q5.市场的主要企业是：

A5. 主要的药物发现技术公司是：

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories

Q6.未来最大的细分市场是什么？

A6.Lucintel 预测，高通量筛检将在预测期内达到最高成长。这是因为高通量筛检作为药物发现方法在製药业被广泛采用，可以快速测试许多物质的生物或生化活性。

Q7.未来五年预计哪个地区的市场成长最大？

A7. 由于健康意识的提高、公共和私人医疗保健支出的增加以及生物技术和製药行业个性化医疗的兴起，对药物发现技术的需求不断增加，预计北美将在预测期内实现最高的增长。 。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球药物发现技术市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球药物发现技术市场趋势（2018-2023）与预测（2024-2030）
  • 按技术分類的全球药物发现技术市场
    • 高通量筛检
    • 基因组学
    • 生物晶片
    • 药物基因组学
    • 生物分析设备
    • 生物资讯学
    • 奈米科技
    • 其他的
  • 按应用分類的全球药物发现技术市场
    • 心血管疾病
    • 帕金森氏症
    • 阿兹海默症
    • 其他的
  • 按最终用途行业分類的全球药物发现技术市场
    • 製药公司
    • 生物製药公司
    • 生技公司
    • 研究所

第四章 2018-2030年区域市场趋势及预测分析

  • 按地区分類的全球药物发现技术市场
  • 北美药物发现技术市场
  • 欧洲药物发现技术市场
  • 亚太药物发现技术市场
  • 其他地区的药物发现技术市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
  • 全球药物发现技术市场新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球药物发现技术市场的能力
    • 全球药物发现技术市场的合併、收购与合资
    • 认证和许可

第七章主要企业概况

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories
简介目录

Drug Discovery Technology Trends and Forecast

The future of the global drug discovery technology market looks promising with opportunities in the pharmaceutical company, biopharmaceutical company, biotech company, and research institute markets. The global drug discovery technology market is expected to reach an estimated $123.5 billion by 2030 with a CAGR of 9.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases, rising consumption of pharmaceutical drugs, as well as, growing investments in R&D and rapid technological development.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Drug Discovery Technology by Segment

The study includes a forecast for the global drug discovery technology by technology, application, end use industry, tech, and region.

Drug Discovery Technology Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • High Throughput Screening
  • Genomics
  • Biochips
  • Pharmacogenomics
  • Bioanalytical Instruments
  • Bioinformatics
  • Nanotechnology
  • Others

Drug Discovery Technology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cardiovascular Diseases
  • Parkinson's
  • Alzheimer's
  • Others

Drug Discovery Technology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Biotech Companies
  • Research Institutes

Drug Discovery Technology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug Discovery Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug discovery technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug discovery technology companies profiled in this report include-

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories

Drug Discovery Technology Market Insights

Lucintel forecasts that high throughput screening is expected to witness the highest growth over the forecast period because it extensively employed in the pharmaceutical business as a method of drug discovery, and it enables a rapid test of many substances' biological or biochemical activities.

Within this market, biopharmaceutical company will remain the largest segment because it comprises a large number of international companies that invest heavily in biopharmaceutical medication research and development.

North America is expected to witness the highest growth over the forecast period due to growing emphasis on wellbeing and health, rising public and private healthcare spending, along with the region's biotech and pharmaceutical industries seeing a rise in demand for drug discovery technologies owing to the rise of personalized medications.

Features of the Global Drug Discovery Technology Market

Market Size Estimates: Drug discovery technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Drug discovery technology market size by technology, application, end use industry, tech, and region in terms of value ($B).

Regional Analysis: Drug discovery technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, application, end use industry, tech, and regions for the drug discovery technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug discovery technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug discovery technology market size?

Answer: The global drug discovery technology market is expected to reach an estimated $123.5 billion by 2030.

Q2. What is the growth forecast for drug discovery technology market?

Answer: The global drug discovery technology market is expected to grow with a CAGR of 9.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the drug discovery technology market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases, rising consumption of pharmaceutical drugs, as well as, growing investments in R&D and rapid technological development.

Q4. What are the major segments for drug discovery technology market?

Answer: The future of the global drug discovery technology market looks promising with opportunities in the pharmaceutical company, biopharmaceutical company, biotech company, and research institute markets.

Q5. Who are the key drug discovery technology market companies?

Answer: Some of the key drug discovery technology companies are as follows:

  • Abbott Laboratories
  • Affymetrix
  • Agilent Technologies
  • Albany Molecular Research
  • ArQule
  • AstraZeneca
  • Bio-Rad Laboratories
  • Caliper Life Sciences
  • Celera
  • Charles River Laboratories

Q6. Which drug discovery technology market segment will be the largest in future?

Answer: Lucintel forecasts that high throughput screening is expected to witness the highest growth over the forecast period because it extensively employed in the pharmaceutical business as a method of drug discovery, and it enables a rapid test of many substances' biological or biochemical activities.

Q7. In drug discovery technology market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth over the forecast period due to growing emphasis on wellbeing and health, rising public and private healthcare spending, along with the region's biotech and pharmaceutical industries seeing a rise in demand for drug discovery technologies owing to the rise of personalized medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the drug discovery technology market by technology (high throughput screening, genomics, biochips, pharmacogenomics, bioanalytical instruments, bioinformatics, nanotechnology, and others), application (cardiovascular diseases, Parkinson's, Alzheimer's, and others), end use industry (pharmaceutical companies, biopharmaceutical companies, biotech companies, and research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug Discovery Technology Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Drug Discovery Technology Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Drug Discovery Technology Market by Technology
    • 3.3.1: High Throughput Screening
    • 3.3.2: Genomics
    • 3.3.3: Biochips
    • 3.3.4: Pharmacogenomics
    • 3.3.5: Bioanalytical Instruments
    • 3.3.6: Bioinformatics
    • 3.3.7: Nanotechnology
    • 3.3.8: Others
  • 3.4: Global Drug Discovery Technology Market by Application
    • 3.4.1: Cardiovascular Diseases
    • 3.4.2: Parkinson's
    • 3.4.3: Alzheimer's
    • 3.4.4: Others
  • 3.5: Global Drug Discovery Technology Market by End Use Industry
    • 3.5.1: Pharmaceutical Companies
    • 3.5.2: Biopharmaceutical Companies
    • 3.5.3: Biotech Companies
    • 3.5.4: Research Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Drug Discovery Technology Market by Region
  • 4.2: North American Drug Discovery Technology Market
    • 4.2.1: North American Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.2.2: North American Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes
  • 4.3: European Drug Discovery Technology Market
    • 4.3.1: European Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.3.2: European Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes
  • 4.4: APAC Drug Discovery Technology Market
    • 4.4.1: APAC Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.4.2: APAC Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes
  • 4.5: ROW Drug Discovery Technology Market
    • 4.5.1: ROW Drug Discovery Technology Market by Technology: High throughput screening, Genomics, Biochips, Pharmacogenomics, Bioanalytical instruments, Bioinformatics, Nanotechnology, and Others
    • 4.5.2: ROW Drug Discovery Technology Market by End Use Industry: Pharmaceutical companies, Biopharmaceutical companies, Biotech companies, and Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug Discovery Technology Market by Technology
    • 6.1.2: Growth Opportunities for the Global Drug Discovery Technology Market by Application
    • 6.1.3: Growth Opportunities for the Global Drug Discovery Technology Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Drug Discovery Technology Market by Region
  • 6.2: Emerging Trends in the Global Drug Discovery Technology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug Discovery Technology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug Discovery Technology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Affymetrix
  • 7.3: Agilent Technologies
  • 7.4: Albany Molecular Research
  • 7.5: ArQule
  • 7.6: AstraZeneca
  • 7.7: Bio-Rad Laboratories
  • 7.8: Caliper Life Sciences
  • 7.9: Celera
  • 7.10: Charles River Laboratories